
Emmaus Life Sciences Inc (QB) (EMMA)
USOTC
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.017 | 0.017 | 0.01625 | 3706 | 0.01665712 | CS |
4 | 0.00295 | 20.9964412811 | 0.01405 | 0.0199 | 0.013 | 21489 | 0.01866464 | CS |
12 | -0.002425 | -12.4839124839 | 0.019425 | 0.025 | 0.012 | 22572 | 0.01574817 | CS |
26 | 0.002 | 13.3333333333 | 0.015 | 0.047 | 0.0039 | 50510 | 0.01803628 | CS |
52 | -0.074385 | -81.3973846911 | 0.091385 | 0.10115 | 0.0001 | 53449 | 0.01886118 | CS |
156 | -0.343 | -95.2777777778 | 0.36 | 0.6 | 0.0001 | 32302 | 0.12207005 | CS |
260 | -1.593 | -98.9440993789 | 1.61 | 4 | 0.0001 | 25687 | 0.52683287 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.